Bill Search

  • Introduced
    Jan 30, 2024
  • Passed Senate
  • Passed House
  • Signed into Law
SB 2246
Tennessee Senate Bill
Did you know we offer free bill tracking in Congress and 50 states, and a great mobile app? Sign up here
Drugs, Prescription - As enacted, authorizes a healthcare provider licensed as a nurse or physician assistant to prescribe a buprenorphine product as approved by the FDA for use in recovery or medication-assisted treatment if certain criteria are met. - Amends TCA Title 33; Title 53; Title 63 and Title 68.
Last Action See all actions
executive • May 28, 2024: Comp. became Pub. Ch. 980
Latest Bill Text See all bill texts

Official Summary/Bill Text

Comments on SB 2246

Tweets

Whip Lists

Sponsors
Votes
Actions
  • May 28, 2024 | executive
    • Comp. became Pub. Ch. 980
  • Apr 22, 2024 | Senate
    • Companion House Bill substituted
  • Apr 19, 2024 | Senate
    • Placed on Senate Regular Calendar for 4/22/2024
  • Apr 03, 2024 | Senate
    • Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 7, Nays 2 PNV 0
  • Mar 27, 2024 | Senate
    • Placed on Senate Health and Welfare Committee calendar for 4/3/2024
  • Mar 20, 2024 | Senate
    • Reset on Final calendar of Senate Health and Welfare Committee
  • Mar 13, 2024 | Senate
    • Placed on Senate Health and Welfare Committee calendar for 3/19/2024
  • Feb 01, 2024 | Senate
    • Passed on Second Consideration, refer to Senate Health and Welfare Committee
  • Jan 31, 2024 | Senate
    • Introduced, Passed on First Consideration
  • Jan 30, 2024 | Senate
    • Filed for introduction